The female reproductive tract is unique in its capacity to remodel constantly throughout adult reproductive life. The mechanisms of tissue breakdown, as seen at menstruation and parturition, have been subject to several recent reviews (Hulboy et al., 1997; Salamonsen and Lathbury, 2000; Curry and Osteen, 2001 ) and will be reviewed only briefly here. This article will also examine what is known of the mechanisms of tissue repair, which have not been well studied in the reproductive tract. Possible mechanisms will be indicated by inference from studies on repair in other situations and the need for further research will be highlighted.
Tissue injury

Menstruation
Menstruation is the loss of most of the functionalis layer of the endometrium of women, accompanied by bleeding, that occurs after withdrawal of steroid hormone support at the end of each menstrual cycle. Since the start of the 1990s, there has been a paradigm shift in the view of the mechanisms underlying menstruation, from a process that is initiated and maintained primarily by vascular events, to a process in which tissue destruction is a key feature.
During the late luteal phase of the cycle, widespread degeneration is observed in the basal lamina supporting the decidualized endometrial cells and the endothelium of blood vessels (Roberts et al., 1992) . Scanning electron microscopy (Ludwig and Spornitz, 1991) has revealed that small lesions are apparent in the luminal epithelium on day 28 of the normal cycle. There is then very rapid but incomplete degeneration of the functionalis layer, exposing open blood vessels and glands. It can therefore be surmised that the primary event initiating menstruation is tissue destruction and that loss Email: lois.salamonsen@med.monash.edu.au of blood vessel integrity is one consequence of this. Ancillary mechanisms have also evolved to ensure that the blood does not clot (Lockwood and Schatz, 1996) and that the bleeding stops by the time the tissue destruction has ceased (Salamonsen et al., 1999a) . Vasoactive mediators such as prostaglandins, endothelins and nitric oxide have important roles in regulating blood loss (Salamonsen et al., 1999b ) but these will not be discussed further in this review. Evidence now supports the concept that endometrial destruction is a consequence of the action of matrix degrading enzymes on extracellular matrix, both fibrillar matrix and basal lamina, with resultant loss of blood vessel integrity and shedding of most of the functionalis layer. These data are summarized below.
Menstruation is initiated by the fall in concentrations of oestrogen and progesterone resulting from the demise of the corpus luteum late in the menstrual cycle. The key evidence that menstruation is triggered by loss of steroid support of the tissue is that: (1) if progesterone concentrations are maintained artificially, menstruation does not occur; (2) administration of the progesterone receptor antagonist, mifepristone, during the proliferative and secretory phases of the cycle, results in uterine bleeding; (3) withdrawal of oestrogen and progesterone, as in the case of cyclical contraceptive use, results in uterine bleeding. However, oestrogen and progesterone concentrations fall rapidly with corpus luteum degeneration in all mammals with oestrous cycles, whereas only women and some old-world primates menstruate. Thus, there must be idiosyncrasies of the primate endometrium that regulate menstruation.
Hypoxia. The dogma regarding mechanisms of menstruation originated from the studies of Markee (1940) , who examined the morphological changes in autologous endometrium transplanted to the anterior of the eye of the rhesus monkey, and postulated that the tissue destruction occurred by necrosis resulting from anoxia after constriction of the spiral arterioles. Furthermore, as the spiral arterioles are specific to the endometrium of primates that menstruate, it appeared reasonable that menstruation was dependent upon them. This hypothesis was questioned as early as 1961 by Hisaw and Hisaw (1961) , who observed that menstruation still occurred in the endometrium of primates that had undergone atrophy and had no such coiled arteries. Furthermore, the occurrence of widespread anoxia has not been substantiated in the human endometrium: indeed the transcription factors HIF-1␣ and HIF-2␣, which represent the earliest known response to hypoxia, are barely detectable in the human endometrium and are not widespread during the peri-menstrual phase (Zhang and Salamonsen, 2002a) , indicating that mechanisms other than hypoxia are responsible for initiating menstruation.
Inflammatory response. Inflammation is characterized by tissue oedema, recruitment of inflammatory cells to an area and associated release of pro-inflammatory cytokines. Finn (1986) postulated that menstruation could be regarded as an inflammatory process. There is a marked increase in the total number of leucocytes in the endometrium immediately before menstruation, when they comprise up to 40% of the total cells within the stromal compartment (Salamonsen and Woolley, 1999) . In particular, cells of the myeloid lineage (neutrophils, eosinophils, macrophages or monocytes) are abundant. Mast cells become highly activated and release granular contents into the local microenvironment, and eosinophil products are also detected extracellularly. Cells of lymphoid origin, particularly uterine natural killer cells, are also present in the tissue in substantial numbers, but they appear somewhat earlier during the secretory phase, indicating a primary role in implantation and establishment of pregnancy (King et al., 1998) .
Current data indicates that the inflammatory response in the endometrium occurs in response to the withdrawal of progesterone. Endometrial and peripheral blood leucocytes do not express progesterone receptors (summarized in Salamonsen et al., 2002) , indicating that the recruitment of leucocytes into the endometrium is mediated indirectly via resident cells expressing progesterone receptors. A number of chemoattractive molecules (chemokines) are synthesized by endometrial cells (for a review, see Salamonsen et al., 2002) and at least one of these (interleukin 8 (IL-8); Kelly et al., 1994) is negatively regulated by progesterone. It is likely that chemokines produced by resident cells attract leucocytes to the endometrium just before menstruation. When activated, leucocytes produce a plethora of regulatory molecules, including cytokines, chemokines and a range of enzymes that are important either directly in matrix degradation, or indirectly by activation of other proteases. The known leucocyte proteases are detailed in Table 1 . Such mechanisms are clearly of importance at menstruation.
Matrix degrading enzymes. Immediately before and during menstruation, there is induction of the expression, secretion and activation of matrix metalloproteinases (MMPs), proteases that together have the capacity to degrade all of the components of the extracellular matrix. Importantly, these enzymes are secreted in latent forms, and must be activated extracellularly: this can be achieved by a variety of enzymes, including other MMPs (particularly MMP-3, MMP-9 and MT1-MMP) and by leucocyte proteases such as tryptase and elastase. If a number of latent enzymes are present within a microenvironment, activation of one enzyme, such as MMP-3, can lead to a cascade of subsequent activations. Although progesterone is overall inhibitory to the expression of many MMPs, local regulators of MMP transcription (predominantly cytokines) are derived from endometrial stromal, epithelial and vascular cells, as well as leucocytes within the tissue (for a review, see Curry and Osteen, 2001) . Such local regulation can explain the very focal nature of the expression of most MMPs at menstruation. The proMMPs known to be upregulated in the human endometrium at about the time of menstruation are detailed in Table 2 . Important support for a critical role for MMPs in menstruation is that MMP activity, both gelatinase and collagenase (as opposed to immunoreactive protein and mRNA), is significantly increased in the endometrium at menstruation compared with other stages of the cycle (Zhang and Salamonsen, 2002b) , and that specific inhibitors of MMP can prevent the breakdown of endometrial explants in culture (Marbaix et al., 1996) . Natural tissue inhibitors of matrix metalloproteinases (TIMPs), which bind active forms of most MMPs with a 1:1 stoichiometry, are also present in the human endometrium (Zhang and Salamonsen, 1997) . For MMP action within any microenvironment, the active form of an MMP must be in excess of that of TIMPs, thus providing a very fine balance between a stable tissue and a tissue that is degrading. A hypothetical scheme for the events leading to the tissue destruction at menstruation is shown in Fig. 1 .
Parturition
The events of parturition, the shedding of the placenta and the subsequent uterine involution, involve substantial tissue destruction and subsequent repair and remodelling. Most of the mediators known to be involved in placental shedding appear to be similar to those that are important at menstruation: matrix-degrading enzymes, cytokines and growth factors, and products of leucocytes.
Little is known about the molecular mechanisms of placental shedding. Clearly, placental separation results in part from the contractile strain exerted by the myometrium (Deyer et al., 2000) . Incomplete separation usually results from ineffectual uterine contractions. However, before separation, the placental extracellular matrix is likely to be weakened by the actions of proteases, thus permitting its separation from the uterus. Enzymes such as MMP-2 and MMP-9 are well recognized as important for the rupture of the membranes (Xu et al.,
2002) but it is their upregulation within the decidua or chorion that is likely to influence shedding. MMP-9 gene and protein together with MMP-9 activity are increased in choriodecidua during and after spontaneous-onset labour at term (Tsatas et al., 1999) , whereas a decrease in the concentration of TIMPs at the materno-fetal interface during active labour (Riley et al., 1999) would shift the balance between enzymes and inhibitors in favour of C y t o k in e s P r o t e a s e s tissue degradation. Further studies examining regulation of protease production within this tissue and defining the cellular source and precise location of active forms of the enzymes are required.
Tissue repair
Wound healing
Wound healing is a dynamic interactive process involving soluble mediators, blood cells, extracellular matrix and parenchymal cells. It occurs in three phases: inflammation, tissue formation and tissue remodelling (for a review, see Singer and Clark, 1999) . There are certain features of wound healing that are common to all tissues. However, there are important differences between tissues and a range of features from different models are likely to apply to endometrial repair. There are also aspects of wound healing in other adult tissues that appear to not apply to the endometrium, such as the development of granulation tissue that occurs during the healing of most cutaneous wounds and the formation of blood clots which provide important mediators for the initiation of repair.
Most wounds heal with scarring and this is not generally seen in endometrial repair in women, although in mice, postpartum 'nodules' have been reported (Brandon, 1990) . The other situation in which scarless wound repair occurs is in fetal skin wounds. This changes with fetal development, the least scarring being at an early developmental age (Samuels and Tan, 1999) . This scarless repair highlights the similarities between endometrial remodelling and development. The lack of scarring in the fetus is not related to fetal environment; neither amniotic fluid environment nor perfusion by fetal blood prevent scar formation in the wounded adult skin graft (Longaker et al., 1994) . In the sheep fetus, the organization of collagen within the fetal wound is a key factor in the wound scarring pattern; the resultant collagen architecture is reticular and indistinguishable from that in normal tissue. Fetal skin also re-epithelializes faster than adult skin, and there is a reduced inflammatory response (in particular, fewer neutrophils), and a different growth factor response of the tissue. Recent investigations of cytokine profiles in fetal wounds indicate that diminished production of inflammatory cytokines such as IL-6 and IL-8 contribute to low inflammation (Liu et al., 2001 ). In IL-10 (antiinflammatory cytokine)-deficient fetuses, wounds heal with scarring, supporting a role for inflammation in the development of scars (Liechty et al., 2000) . There could be important features in common with healing in the fetus, given that the endometrium heals without scarring.
Intestinal wound healing is also likely to share features with endometrial repair, given that both require repair of mucosal surfaces. Repair of mucosal injury anywhere throughout the gastrointestinal tract is a biphasic process. Initially, intestinal wounds are resurfaced very rapidly from epithelial cells at the edges of the defect. These appear to redifferentiate towards a migratory phenotype with specialized membrane cytoskeletal and matrix-receptor reorganizations and specialized matrix-dependent signalling patterns (Wilson and Gibson 1997; Basson, 2001) . The migrating cells require a necrotic layer, consisting of dead cells, plasma exudates, mucus and fibrin, and if this is removed, restitution is impaired (Wallace et al., 1986) . After re-epithelialization, maturation of the new epithelium occurs under the influence of numerous peptide and non-peptide regulators. The time course of this repair depends greatly on the severity and tissue depth of the injury (Wilson and Gibson, 1997) .
Among the molecules important for wound healing in a range of situations are a wealth of growth factors and cytokines, extracellular matrix molecules such as fibronectin and hyaluronan and their cellular receptors (including the integrins and CD44), and matrix degrading enzymes such as MMPs. Not only the presence or absence of a factor but also the timing of its action appears to be important. For example, IL-1 and tumour necrosis factor ␣ are both beneficial in the early stages of wound repair but deleterious in the later stages (Rumaiia and Borah, 2001) . Although pharmacological application of growth factors and cytokines to wounds has not yielded dramatic clinical benefit, substantial experimental evidence from studies in mice has shown that blocking key molecules will prevent or seriously impair wound repair (Table 3) . Many of these key molecules are also important in tissue degradation.
Endometrial repair
It has been proposed that repair of the human uterine surface is complete within 48 h after the first two menstrual days, and 60 h after mechanically induced trauma in the rodent (Ferenczy, 1976; Ludwig et al., 1990) , on the basis of morphological data from both humans and experimental animals. Indeed, when only the epithelium is lost after oil injection in mice, restoration occurs within 45 min (Finn et al., 1989) . Construction of the uterine epithelial surface appears to precede stromal expansion; stromal mitoses first appear only after re-epithelialization is complete (day 5 or 6 of the human menstrual cycle), coincident with rising oestrogen concentrations, and reach a peak on days 8-10 (Ferenczy et al., 1979) . A similar sequence of events, with re-epithelialization preceding stromal mitosis, is seen in the rhesus monkey (Okulicz et al., 1997). Oestrogen and progesterone receptors (ER and PR) are detected in the glandular epithelium by day 3, and by day 5, when epithelial reconstruction is complete, strong positive staining for ER and PR is present throughout the endometrium (Okulicz and Scarrell, 1998) . Studies with tissue recombinations indicate that the uterine epithelium is required for stromal responsiveness to hormones, and may explain why reepithelialization is the first event in restoration (Bigsby, 2002) . However, it is important to note that even in the absence of all hormonal support (after ovariectomy and endometriotomy), the endometrium stops bleeding and heals, indicating that normal wound healing mechanisms play a role in the reconstruction of the endometrium during menses and that this is facilitated by proliferative factors other than oestrogen.
Re-epithelialization. Scanning electron microscopy (Ferenczy, 1976; Ludwig et al., 1990) has revealed a dual origin for the restoration of the luminal epithelium. Regeneration begins in areas in which the mouths of basal glands are free from overlying degenerated tissue, and there is simultaneous and progressive epithelial outgrowth from these, and ingrowth from the intact peripheral surface membrane bordering the denuded basalis. The stromal tissue starts to grow only when the endometrial wound is completely re-epithelialized. This re-epithelialization has many features in common with that in wound healing in other tissues, but the molecular mechanisms are not yet known.
Vascular repair. Within 5 days of menstrual onset, the damaged endometrial vessels have been repaired (Ludwig and Spornitz, 1991) . This repair occurs simultaneously with breakdown, as does re-epithelialization. Subsequent re-growth of vessels occurs under the influence of oestrogen, together with stromal expansion as the proliferative phase progresses.
Stem cells. Any tissue that undergoes self-renewal (for example, epidermis, haematopoietic system) must establish a life-long population of relatively pliable stem cells. The classic perception that stem cells are undifferentiated is now not strictly held: stem cells can masquerade behind morphological and biochemical features normally attributed to undifferentiated cell types. Indeed, it has been suggested that the only infallible traits of stem cells are their robust proliferative capacity and their ability to self renew (Fuchs and Segre, 2000) . It has been proposed that stem cell reservoirs will be present only in adult tissues that are capable of constant mature cell production or postinjury regeneration (Lemischka, 2001) ; the endometrium certainly fulfils these requirements. Identification of the microenvironments within the niches in a tissue where different types of precursor or stem cells reside is a major challenge for the future.
As early as 1944, Hartman showed that after experimental removal of all visible endometrium (endometriectomy), the entire primate endometrium could regenerate from the few endometrial cells remaining on the surface of the myometrium. Padykula (1991) subsequently postulated that there is a multipotent pool of stem cells within the deeper basalis layer in the human endometrium, capable of producing progenitor cells that further differentiate into epithelial, stromal and endothelial cells. However, there is no evidence to support a single progenitor cell for all types of endometrial cell and it is more likely that there are different precursor cells for each type of cell. In the endometrium in rabbits, quiescent cells in the bottom of the glands proliferate and migrate up through the glands to the lumen (Conti et al., 1984) . Oestrogen administration results in recruitment of glandular quiescent cells into the cell cycle, but has no effect on luminal epithelial cells. After photodynamic epithelial destruction in the endometrium in rabbits, rapid re-epithelialization likewise occurs by proliferation originating in the deeper regions of the glands (Wyss et al., 1996) . Thus, it appears that cells deep in the glands function as a population of stem cells. A similar mechanism is likely in the human endometrium; indeed, basal epithelial cells of some glands are located within the myometrium and may provide the precursors from which the endometrium can re-epithelialize, even after endometriectomy. Stem cells that act as precursors for endometrial stromal fibroblasts have not been identified, although in culture, an unusually high number of doublings has been reported for endometrial stromal cells (Holinka and Gurpide, 1987) . Decidual stromal cells in culture express STRO-1, an antigen that identifies stromal precursors of the bone marrow (Garcia-Pacheco et al., 2001) ; whether this is present in non-decidualized stromal cells or in decidual cells in vivo is not known. As phenotypic alterations of cells in culture occur with time and can be affected by culture conditions, it may be that certain conditions favour the growth of subpopulations derived from a small number of stem cells within the initial tissue samples.
Proteolytic enzymes. During wound healing, cells are required to migrate rapidly into the wound site, via proteolytically generated pathways in the provisional matrix, to produce a new extracellular matrix (ECM) and to remodel the newly formed matrix. During menstruation, proteolytic enzymes including MMPs and serine proteases are present in abundance (Table 1) and it is difficult to establish whether their role is primarily in tissue breakdown or whether they also play a role in repair. Limited proteolysis is important for exposing cryptic cell-binding sites on the ECM that are needed for cell migration. Therefore, the proteinases that are localized to and activated at the contact areas of the ECM and the plasma membrane are likely to be the best candidate enzymes for regulating cell migration (Parks, 1999) . These proteinases include MT-MMPs, MMP-2 and MMP-9, all of which are present in the endometrium during the menstrual phase of the human cycle (Salamonsen and Woolley, 1999) . Other proteases may be important for the release and activation of growth factors needed for endometrial repair (for example, the release of fibroblast growth factor (FGF) from perlecan by the action of MMP-1 and -3 (Whitelock et al., 1996) and the activation of transforming growth factor ␤ (TGF␤) and IL-1␤ from their precursors by the actions of MMP-2 and -9, respectively (Schonbeck et al., 1998; Yu and Stamenkovic, 2000) ). MMP-7, which is strongly expressed in the endometrial epithelium during the menstrual phase, is important for re-epithelialization after wounding in the trachea (Parks et al., 2001) ; in MMP-7-null mice, such wounds do not re-epithelialize within 24 h, the time taken in wildtype animals (Parks, 1999) . Whether MMP-7 is equally important for reepithelialization of the human endometrium remains to be established.
Growth factors. A number of growth factors known to be important in wound healing are expressed in the endometrium and are likely to be important in endometrial repair. These growth factors can be derived from both stromal and epithelial cells or from leucocytes.
Activins. Activins (members of the TGF␤ superfamily) are strongly upregulated during cutaneous wound healing (Munz et al., 1999) , whereas mice overexpressing the natural inhibitor, follistatin, show a severe delay in wound healing (Wankell et al., 2001) . However, the scar area is small when the wounds eventually heal in these mice, indicating a role for activin in scar formation too. Activins, their receptors and follistatin are all present in the human endometrium, with activin A localized particularly to the epithelium, decidualized stromal cells and leucocytes (Jones et al., 2002) . During menstruation, activin A may be present in high concentrations in menstrual fluid and, if so, would be anticipated to play a role in repair mechanisms. Other members of the TGF␤ superfamily including all three TGF␤s have also been implicated in wound healing (Table 3) .
Keratinocyte growth factor (KGF). KGF is a member of the FGF family and its high affinity receptor is present on most types of epithelial cell. Over-expression of KGF in skin leads to hypertrophy of epidermis, although lack of KGF seems to be compensated for by FGF-10 (Werner, 1998) . Skin wounds in receptor-deficient mice have severely delayed re-epithelialization, whereas addition of exogenous KGF to wounds stimulates reepithelialization. In rhesus monkeys, endometrial KGF is upregulated by progesterone and falls markedly during the luteal-to-follicular transition. KGF is not mitogenic on epithelial cells in the endometrium of this primate (Slayden et al., 2000) , but stimulates spiral artery growth and inhibits glandular apoptosis during the secretory phase of the cycle. It may be that a different FGF family member contributes to epithelial regeneration in the endometrium. In humans, FGF-2 mRNA is present in the endometrial stromal compartment, whereas its receptor (FGF-R1) is present on both stromal and epithelial cells, indicating a potential role for FGF-2 in epithelial repair and stromal restoration (Sangha et al., 1997) .
Hepatocyte growth factor (HGF). HGF is a mesenchymal-derived pleiotropic factor that mediates the interactions between mesenchymal and epithelial cells by acting as a mitogen on epithelial cells. It has been suggested that HGF is involved in the regeneration of several tissues. HGF promotes proliferation, migration and lumen formation of endometrial epithelial cells in vitro (Sugawara et al., 1997) ; whether these actions occur in vivo remains to be established.
Vascular endothelial cell growth factor (VEGF). Local administration of a neutralizing anti-VEGF antibody has implicated VEGF in wound angiogenesis (Howdieshell Endothelin. Endothelin, although known primarily as a vasoconstrictor, also has marked mitogenic actions. In the human endometrium, endothelin 1 is the predominant isoform and is maximally expressed during the late secretory and menstrual phases by epithelial, endothelial and decidualized stromal cells. It has been proposed that endothelin 1 has roles in both the cessation of bleeding and tissue repair (Salamonsen et al., 1999a) .
Inflammatory cells. Inflammatory cells play an important role in cutaneous wound healing (Singer and Clark, 1999) and are present in substantial numbers in the menstruating endometrium (Salamonsen and Woolley, 1999) . It is difficult to differentiate between the contribution of these cells to endometrial breakdown and their role in repair, but certainly during the early stage of repair, regulatory factors derived from leucocytes are likely to be important. For example, interactions among macrophages, eosinophils and their chemokines clearly contribute to epithelial growth in normal and cancer states including mammary gland development (GouonEvans et al., 2002).
Chemokines. Chemokines, cytokines best known for their chemoattractive properties, attract leucocytes into tissues and are present in many leucocytes and endometrial epithelial, stromal and vascular cells. Evidence now supports a broad range of functions for chemokines that indicate important roles in tissue repair (see Salamonsen et al., 2002) . For example, IL-8, which is expressed in endometrial vessels (Jones et al., 1997) , has angiogenic properties (Koch et al., 1992) and enhances re-epithelialization of skin grafts (Rennekampff et al., 2000) . A proposed scheme for tissue restoration after breakdown in the endometrium is shown in Fig. 2 .
Uterine involution
Uterine involution requires massive remodelling of the extracellular matrix in association with cell proliferation and apoptosis as the uterus returns to the pre-pregnancy state (Takamoto et al., 1998) . This is related primarily to the loss of collagen. Postpartum involution of the uterus is markedly impaired in mice carrying mutations that make collagen type I resistant to collagenase action (Liu et al., 1995) . Uterine involution has been studied most extensively in the rat; indeed the enzyme matrilysin (MMP-7) was first identified because of its high expression in the postpartum uterus where it reaches peak expression on days 1-2 (Woessner, 1996) . Its regulation at this time is not fully understood, although loss of progesterone and mechanical distention are likely contributors. MMP-7 is localized to the epithelial cell surface in an MMP-7-HB-EGF-ErbB4 complex that is assembled by the membrane cell surface proteoglycan CD44. Postpartum uterine involution is accelerated in CD44 null mice (Yu et al., 2002) . In these animals, MMP-7 is redistributed from the apical to the basal compartment, indicating that mislocalized MMP-7 activity results in accelerated basement membrane degradation. In MMP-7 and MMP-3 null mice, there are no changes in uterine involution; however, considerable upregulation of other MMPs occurs, presumably providing compensation (Rudolph-Owen et al., 1997) . Neutrophil collagenase (MMP-8) is also highly expressed in the postpartum uterus, and can be activated by MMP-7 (Balbin et al., 1998) .
The puerperium in women is defined as the period of 6-8 weeks after delivery during which the uterus, which weighs more than one kilogram soon after delivery, undergoes physiological involution and returns to the non-pregnant state. A recent longitudinal study using ultrasonography has provided important information (Mulic-Lutvica et al., 2001 ), supporting earlier histological data (Williams, 1931) . During the first three days postpartum, the endometrium is very thin; a variable amount of decidual tissue can be retained after labour. A normal healing process appears to occur from day 7 to day 17, along with abundant shedding of lochia. From days 26-56, the endometrium appears to be inactive (probably resembling proliferative phase tissue), and reflects the completed involution. However, because of the difficulties of sampling, nothing is known specifically of the molecular mechanisms underlying uterine involution in women.
Conclusion
Although the past decade has seen considerable advance in our understanding of the processes of tissue damage and breakdown in the endometrium, almost nothing is known of how endometrial repair is achieved after menstruation or parturition. It is clear that repair is very rapid, that it occurs without scarring, and that the endometrium can be regenerated even after its almost complete removal. Many of the factors involved in tissue remodelling in the uterus are otherwise most commonly expressed during development or in pathologies or cancer. Although mechanisms of breakdown are considered critical in providing explanations for abnormal uterine bleeding in women, repair mechanisms are likely to be of equal importance and it is hoped that a clearer understanding of these mechanisms will be achieved during the current decade. 
